Change in alpha glutathione s-transferase levels during liver resection

Hepato-Gastroenterology

Volumn 51, Issue 60, 2004, Pages 1747-1750

  Suehiro, Taketoshi ^a,b   Matsumata, Takashi ^a   Shikada, Yasunori ^a   Shimada, Mitsuo ^a   Shirabe, Ken ^a   Sugimachi, Keizo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

GST; Liver resection

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYTOPLASM PROTEIN; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT CARCINOMA; CLINICAL ARTICLE; COLON CARCINOMA; DIAGNOSTIC KIT; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HALF LIFE TIME; HUMAN; LIVER CELL; LIVER CELL CARCINOMA; LIVER CELL DAMAGE; LIVER FUNCTION TEST; LIVER LOBECTOMY; LIVER RESECTION; LIVER SEGMENTECTOMY; MALE; PARTIAL HEPATECTOMY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN SECRETION; STOMACH CARCINOMA;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; FEMALE; GLUTATHIONE TRANSFERASE; HEPATECTOMY; HUMANS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; PERIOPERATIVE CARE; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 6344291149     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Rees GW, Trull AK, Doyle S: Evaluation of an enzyme-immunometric assay for serum alpha-glutathione s-transferase. Ann Clin Biochem 1995; 32:575-583.
2. Mizushima A, Kawauchi Y, Kugiyama T: Glutathione S-transferase: a new sensitive index of hepatocellular integrity and perioperative management. J Clin Anesth (Japan) 1997; 21:1359-1367.
3. Hughes VF, Trull AK, Gimson A. Friend PJ, Jamieson N, Duncan A, Wight DGD, Prevost AT, Alexander GJM: Randomized trial to evaluate the clinical benefits of serum alpha-glutathione s-transferase concentration monitoring after liver transplantation. Transplantation 1997; 64:1446-1452.
4. Trull AK, Facey SP, Rees GW, Wight DGD, Noble-Jamieson G, Joughin C, Friend PJ, Alexander GJM: Serum alpha-glutathione s-transferase: a sensitive marker of hepatocellular damage associated with acute liver allograft rejection. Transplantation 1994; 58:1345-1351.
5. Kilty C, Doyle S, Hassett B, Manning F: Glutathione S-transferase as biomarkers of organ damage: applications of rodent and canine GST enzyme immunoassays. Chemico-Biological Interactions 1998; 111-112:123-135.
6. Loguerico C, Tuccillo C, Caporaso N, Del Vacchio Bianco G, Morisco F, Guerrieero C, Di Santolo SS, Valenza LM, Del Veccio Bianco C: Determination of plasma alpha-glutathione S-transferase in patients with HCV-related chronic infection: Its significance and possible clinical relevance. Liver 1998; 18:166-172.
7. Vaubourdolle M, Chazouilleres O, Briaud I, Legendre C, Serfaty L, Poupon R, Giboudeau J: Plasma alpha-gultathione S-transferase assessed as a marker of liver damage in patients with chronic hepatitis C. Clin Chem 1995; 41:1716-1719.
8. Boran M, Cetin S: Plasma alpha-glutathione S-transferase (GST) as a marker of liver damage in hemodialysis patients. Nephrol Dialysis Transplant 1998; 13:1323-1324.
9. Thorburn D, Bird G, Spence E, McSween R, Mills P: Alpha-glutathione S-transferase levels in chronic hepatitis C infection and the effect of alpha-interferon therapy. Clinica Chimica Acta 1996; 253:171-180.
10. Boran M, Cetin S: The role of alpha-glutathione S-transferase in the monitoring of hemodialysis patients with hepatitis C virus infection undergoing high-dose interferon-alpha2b therapy. Nephron 1999; 82:22-26.
11. Laurent TC, Fraser JRE: Hyaluronan. FASEB J 1992; 6:2397-2404.
12. Reed RK, Laurent UBG: Turnover of hyaluronan in the microcirculation. Am Rev Respir Dis 1992; 146:S37-S39.
13. Fraser JRE, Laurent TC, Laurent AE, Laurent UGB: Elimination of hyaluronic acid from the blood stream in the human. Clin Exp Pharm Physiol 1984; 11:17-25.
14. Fraser JRE, Alcorn D, Laurent TC, Robinson AD, Ryan GB: Uptake of circulating hyaluronic acid by the rat liver: cellular localization in situ. Cell Tissue Res 1985; 242:505-510.
15. Fraser JRE, Laurent AE, Nyberg A, Laurent TC: Removal of hyaluronic acid from the circulation in rheumatoid disease and primary biliary cirrhosis. J Lab Clin Med 1986; 107:79-85.
16. Frebourg T, Delpech B, Bercoffe, Senant J, Bertrand P, Deugnier Y, Bourreille J: Serum hyaluronate in liver disease: study by enzymoimmunological assay. Hepatology 1986; 6:392-395.
17. Suehiro T, Boros P, Emre S, Sheiner P, Guy S, Schwartz ME, Miller CM: Assessment of liver allograft function by hyaluronic acid and endothelin levels. J Surg Res 1997; 73:123-128.
18. Suehiro T, Matsumata T, Kitamura M, Iso Y, Nagamatsu Y, Funahashi S, Nozoe T, Ishikawa H, Okamoto M: Change in blood alpha-glutathione-s-transferase and hyaluronic acid levels during liver resection. Hepatology 1997; 26:245A.